COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,238 Articles (22,733 medRxiv, 8,505 bioRxiv)

Most recent first Previous |  Page 984: Articles 9831-9840  | Next

Investigating sensitivity of nasal or throat (ISNOT): A combination of both swabs increases sensitivity of SARS-CoV-2 rapid antigen tests
Goodall, B. L., LeBlanc, J. J., Hatchette, T. F., Barrett, L., Patriquin, G.
10.1101/2022.01.18.22269426 — Posted: 2022-01-21
mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients
Teresa Lupo Stanghellini, M., Di Cosimo, S., Costantini, M., Monti, S., Mantegazza, R., Mantovani, A., Salvarani, C., Luigi Zinzani, P., Inglese, M., Ciceri, F., Apolone, G., Ciliberto, G., Baldanti, F., Morrone, A., Sinno, V., Locatelli, F., Notari, S., Turola, E., Giannarelli, D., Silvestris, N.
10.1101/2022.01.18.22269351 — Posted: 2022-01-21
Combination of Spironolactone and Sitagliptin Improves Clinical Outcomes of Outpatients with COVID-19: An Observational Study
Davarpanah, M. A., Adatorwovor, R., Mansoori, Y., Ramsheh, F. S. R., Parsa, A., Hajiani, M., Faramarzi, H., Kavuluru, R., Asadipooya, K.
10.1101/2022.01.21.22269322 — Posted: 2022-01-21
ReadItAndKeep: rapid decontamination of SARS-CoV-2 sequencing reads
Hunt, M., Swann, J., Constantinides, B., Fowler, P. W., Iqbal, Z.
10.1101/2022.01.21.477194 — Posted: 2022-01-21
Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline) - Based Stabilizer for Aerosol Treatment of COVID-19
Ramsey, J. D., Stewart, I. E., Madden, E. A., Lim, C., Hwang, D., Heise, M. T., Hickey, A. J., Kabanov, A. V.
10.1101/2022.01.21.477258 — Posted: 2022-01-21
Outbreak.info: A standardized, searchable platform to discover and explore COVID-19 resources and data
Tsueng, G., Mullen, J., Alkuzweny, M., Cano, M. A., Rush, B., Haag, E., Outbreak Curators, , Latif, A. A., Zhou, X., Qian, Z., Andersen, K. G., Wu, C., Su, A. I., Gangavarapu, K., Hughes, L. D.
10.1101/2022.01.20.477133 — Posted: 2022-01-21
Sialic acid and fucose residues on the SARS-CoV-2 receptor binding domain modulate IgG reactivity
Samuelsson, E., Mirgorodskaya, E., Nyström, K., Bäckström, M., Liljeqvist, J.-A., Norden, R.
10.1101/2022.01.20.477056 — Posted: 2022-01-21
Microbial GWAS studies revealing combinations of Omicron RBD mutations existed and may contribute to antibody evasion and ACE2 binding
Ou, X., Yang, Z., Zhu, D., Mao, S., Wang, M., Jia, R., Chen, S., Liu, M., Yang, Q., Wu, Y., Zhao, X., Zhang, S., Huang, J., Gao, Q., Liu, Y., Zhang, L., Peppelenbosch, M., Pan, Q., Cheng, A.-c.
10.1101/2022.01.19.22269510 — Posted: 2022-01-21
Monitoring SARS-CoV-2 genome evolution in a localized population
Gupta, A., Basu, R., Bashyam, M. D.
10.1101/2022.01.19.22269572 — Posted: 2022-01-21
Joinpoint Regression to Determine the Impact of COVID-19 on Mortality in Europe: A Longitudinal Analysis From 2000 to 2020 in 27 Countries
Rovetta, A.
10.1101/2022.01.19.22269576 — Posted: 2022-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).